PharmaBoardroom

Bee Lim – Director, Healthcare Strategy & Marketing,…

UPS APAC's Bee Lim describes how the logistics giant responded to the unprecedented challenges thrown up by the COVID-19 pandemic, the trends that the…

Alejandro Paolini – Managing Director Mexico, Central…

Alejandro Paolini, Siemens Healthineers’ managing director for Mexico, Central America and Caribbean, dives into the medical technology industry’s…

Bülent Akarcali – Chairman, NBA Consulting, Turkey

Turkey’s former Minister of Health, Bülent Akarcali, outlines the country’s healthcare system evolution over the past decades, comparing the…

Héctor Orellana – VP North Latin America, Medtronic

Medtronic’s VP for North Latin America, Héctor Orellana, outlines the largest company’s new vision for that region, their efforts and challenges…

IP PACT: A Journey, Not a Destination

The issue of COVID-19 vaccine access in developing nations has thrust intellectual property (IP) into global headlines. Against the backdrop of heated…

Charles Stacey – President & CEO, Cerecin

Cerecin’s Charles Stacey outlines the company’s progress in expanding its lead asset into migraine and infantile spasms, how its funding strategy…

Biosimilars & Biologics: Mexico

Key facts about biosimilars and biologics in Mexico. Prepared in association with Olivares, a leading global law firm, this is an extract from The…

Localization: Mexico

Key facts about Localization in Mexico. Prepared in association with Olivares, a leading global law firm, this is an extract from The Pharma Legal…

Moderna: Bullish Bancel “Not Losing Sleep” over COVID-19…

The day the Biden administration announced its support for the waiver of IP rights for COVID-19 vaccines, Moderna’s stock fell six percent; the…

Orphan Drugs & Rare Diseases: Mexico

Important legal info for orphan drugs and rare diseases in Mexican pharma. Prepared in association with Olivares, a leading global law firm, this is…

Japan Pharma News: Takeda’s Revenue up 5x; First Domestic…

The latest from Japanese pharma, including Takeda’s big profit jump, British Linepharma’s quest to get the first ever induced abortion pill for…

Susanne Caspar – CEO, Linnea

Susanne Caspar, CEO at Swiss natural API producer Linnea, talks about her first few months in the company, the pharmaceutical industry’s growing…

Tagged with A